Efficacy of Amalaki Rasayana and Cap. Max HB in the management of ‘Sannipataja Pandu Roga’ W.S.R. to Sickle Cell Anaemia
Phase 2
Completed
- Conditions
- Health Condition 1: D648- Other specified anemias
- Registration Number
- CTRI/2023/03/050760
- Lead Sponsor
- Central Council for Research in Ayurvedic Sciences (CCRAS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
1.Patients between 18-50 yrs. of age, and regular diet habit.
2.Patients will be selected from Pathology laboratory of Roganidan and O.P.D. & I.P.D. of Kayachikitsa department of the institute.
3.Patients Having Hb 07-10 g/dl with moderate Anemia..
4.Patients with confirm Positive sickling test with Type: HbAS or HbSS and presenting sign & symptoms of Sickle cell Anemia.
5.Patients willing to participate in clinical trial.
Exclusion Criteria
1.Patients who are pregnant and Lactating mother.
2.Patient Severe illness like Tuberculosis, Cancer, Cirrhosis of liver, aplastic anaemia etc. also be excluded.
3.Patients who will not come for regular follow up.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ( subjective criteria) <br/ ><br>Dutch-AIMS2 - HFF, Symptoms severity scale method 2006. <br/ ><br>Timepoint: 8 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method (Objective criteria):- <br/ ><br>1.Haematological investigations (CBC –Hb %, RBC count, MCV, MCH, MCHC) <br/ ><br>2.Sickling test by 2% sodium metabisulphite & Sickling Solubility test <br/ ><br>3.Radiological investigations ( if required) <br/ ><br>Timepoint: 8 weeks <br/ ><br>